핵의약학 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별(의료기관용, 상업용), 용도별(진단용, 치료용), 지역별 세분화 및 경쟁 구도(2020-2030년)
Nuclear Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Institutional and Commercial), By Purpose (Diagnostic and Therapeutic), By Region and Competition, 2020-2030F
상품코드:1879359
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 핵의약학 시장은 2024년에 59억 9,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 7.92%로 성장하여 94억 6,000만 달러에 이를 것으로 예측됩니다.
핵약학은 핵의학에서 환자에게 투여할 목적으로 방사성 물질을 준비 및 조제하는 분야로, 진단 및 치료 목적으로 방사성의약품을 활용하는 분야입니다. 시장 성장은 암, 심혈관 질환 등 만성질환 증가, 핵의학 기술의 발전, 개인 맞춤형 의료에 대한 수요 증가, 종양학 및 신경학 분야에서의 적용 범위 확대에 의해 주도되고 있습니다.
The Global Nuclear Pharmacy Market, valued at USD 5.99 Billion in 2024, is projected to experience a CAGR of 7.92% to reach USD 9.46 Billion by 2030. Nuclear pharmacy involves the preparation and dispensing of radioactive materials for patient administration in nuclear medicine, utilizing radiopharmaceuticals for diagnostic and therapeutic purposes. Market growth is driven by the increasing prevalence of chronic diseases like cancer and cardiovascular disorders, advancements in nuclear medicine technologies, and a growing demand for personalized medicine, expanding applications across oncology and neurology.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.99 Billion
Market Size 2030
USD 9.46 Billion
CAGR 2025-2030
7.92%
Fastest Growing Segment
Institutional
Largest Market
North America
Key Market Drivers
The global nuclear pharmacy market is significantly influenced by two major driving factors: the rising burden of chronic diseases and continuous advancements in radiopharmaceutical development. The increasing global burden of chronic diseases represents a primary impetus for the nuclear pharmacy market, necessitating sophisticated diagnostic and therapeutic interventions. Conditions like cancer, cardiovascular disorders, and neurodegenerative diseases exhibit growing prevalence worldwide, driving escalating demand for early, accurate detection and targeted treatment. Nuclear medicine, offering functional and molecular imaging, proves crucial in disease staging, treatment monitoring, and personalized therapy selection.
Key Market Challenges
A significant challenge impeding the Global Nuclear Pharmacy Market's growth is the persistent supply chain disruptions and shortages of critical radioisotopes. The inherently short half-lives of these materials, such as Technetium-99m, necessitate complex and highly efficient logistics, making the supply chain exceptionally vulnerable to any interruption in production or distribution. This reliance on a limited number of aging nuclear reactors for isotope generation, coupled with unpredictable maintenance schedules or unexpected outages, frequently leads to insufficient supply.
Key Market Trends
The emergence of targeted alpha therapies significantly influences the global nuclear pharmacy market by introducing a potent and precise cancer treatment modality. These therapies deliver highly localized radiation using alpha-emitting isotopes, effectively targeting malignant cells with minimal damage to healthy tissues, thus expanding therapeutic options. In January 2025, a Society of Nuclear Medicine and Molecular Imaging (SNMMI) strategy meeting indicated two-thirds of physicians anticipated over 10% growth in therapy at their facilities within the year. This is reinforced by Sanofi's AlphaMedix (Lead-212-DOTAMTATE) receiving FDA Breakthrough Therapy Designation in February 2024, followed by positive Phase 2 results for gastroenteropancreatic neuroendocrine tumors in October 2025.
In this report, the Global Nuclear Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Nuclear Pharmacy Market, By Type:
Institutional
Commercial
Nuclear Pharmacy Market, By Purpose:
Diagnostic
Therapeutic
Nuclear Pharmacy Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Nuclear Pharmacy Market.
Available Customizations:
Global Nuclear Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Nuclear Pharmacy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Institutional, Commercial)
5.2.2. By Purpose (Diagnostic, Therapeutic)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Nuclear Pharmacy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Purpose
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Nuclear Pharmacy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Purpose
6.3.2. Canada Nuclear Pharmacy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Purpose
6.3.3. Mexico Nuclear Pharmacy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Purpose
7. Europe Nuclear Pharmacy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Purpose
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nuclear Pharmacy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Purpose
7.3.2. France Nuclear Pharmacy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Purpose
7.3.3. United Kingdom Nuclear Pharmacy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Purpose
7.3.4. Italy Nuclear Pharmacy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Purpose
7.3.5. Spain Nuclear Pharmacy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Purpose
8. Asia Pacific Nuclear Pharmacy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Purpose
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Nuclear Pharmacy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Purpose
8.3.2. India Nuclear Pharmacy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Purpose
8.3.3. Japan Nuclear Pharmacy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Purpose
8.3.4. South Korea Nuclear Pharmacy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Purpose
8.3.5. Australia Nuclear Pharmacy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Purpose
9. Middle East & Africa Nuclear Pharmacy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Purpose
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Nuclear Pharmacy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Purpose
9.3.2. UAE Nuclear Pharmacy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Purpose
9.3.3. South Africa Nuclear Pharmacy Market Outlook
